Metabolites
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB21575 | Ubiquinol-2 | TCA cycle (ubiquinol-2) PW001002 | (C5H8)nC14H20O4 | ||
ECMDB20619 | Ubiquinol-10 5677-55-4 | 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-decamethyltetraconta-2,6,10,14,18,22,26,30,34,38-decaen-1-yl]-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-diol | TCA cycle (ubiquinol-10) PW001010 | 865.3594 C59H92O4 | |
ECMDB21574 | Ubiquinol-1 | 2,3-dimethoxy-5-methyl-6-(3-methylbut-2-en-1-yl)benzene-1,4-diol | 252.3062 C14H20O4 | ||
ECMDB24056 | Ubiquinol 8 | 2,3-dimethoxy-5-methyl-6-[(2E,6E,10E,14E,18E,22E,26E)-3,7,11,15,19,23,27,31-octamethyldotriaconta-2,6,10,14,18,22,26,30-octaen-1-yl]benzene-1,4-diol | 731.1412 C49H78O4 | ||
ECMDB00306 | Tyramine 51-67-2 | 4-(2-aminoethyl)phenol | 137.179 C8H11NO | ||
ECMDB23864 | tRNA(Tyr) | (3S)-3,6,8-trihydroxy-1,2,3,4-tetrahydronaphthalen-1-one | 194.186 C10H10O4 | ||
ECMDB23878 | tRNA(Ala) | (3R,4R,5R)-5-{[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy}oxane-2,3,4-triol | 282.245 C10H18O9 | ||
ECMDB03379 | Triphosphate 14127-68-5 | {[hydroxy(phosphonooxy)phosphoryl]oxy}phosphonic acid | 252.9153 O10P3 | ||
ECMDB04161 | Trimethylamine N-Oxide 1184-78-7 | N,N-dimethylmethanamine oxide | 75.1097 C3H9NO | ||
ECMDB00906 | Trimethylamine 75-50-3 | trimethylamine | 59.1103 C3H9N | ||
ECMDB21411 | Triethanolamine 102-71-6 | 2-[bis(2-hydroxyethyl)amino]ethan-1-ol | 149.1882 C6H15NO3 | ||
ECMDB01124 | Trehalose 6-phosphate 4484-88-2 | {[(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]methoxy}phosphonic acid | Starch and sucrose metabolism PW000941 | 422.2764 C12H23O14P | |
ECMDB00975 | Trehalose 99-20-7 | (2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-{[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxane-3,4,5-triol | Starch and sucrose metabolism PW000941 | 342.2965 C12H22O11 | |
ECMDB21363 | Trans-Octadec-2-enoyl-CoA | {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[(3R)-3-hydroxy-2,2-dimethyl-3-{[2-({2-[(2E)-octadec-2-enoylsulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}propoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid | fatty acid oxidation (steareate) PW001024 | 1031.98 C39H68N7O17P3S | |
ECMDB20611 | trans-Delta2, cis-delta4-decadienoyl-CoA | 4-({[({[(2S,3S,4R,5S)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-N-(2-{[2-(deca-2,4-dienoylsulfanyl)ethyl]-C-hydroxycarbonimidoyl}ethyl)-2-hydroxy-3,3-dimethylbutanimidic acid | 917.75 C31H50N7O17P3S | ||
ECMDB00930 | trans-Cinnamic acid 140-10-3 | (2E)-3-phenylprop-2-enoic acid | 148.1586 C9H8O2 | ||
ECMDB00958 | trans-Aconitic acid 4023-65-8 | (1E)-prop-1-ene-1,2,3-tricarboxylic acid | Secondary Metabolites: Glyoxylate cycle PW000967 | 174.1082 C6H6O6 | |
ECMDB20198 | Trans-4-Carboxymethylenebut-2-en-4-olide 22752-92-7 | 2-[(2Z)-5-oxo-2,5-dihydrofuran-2-ylidene]acetic acid | 140.0936 C6H4O4 | ||
ECMDB03944 | trans-2-Hexenoyl-CoA 10018-93-6 | {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-2-{[({[(3-{[2-({2-[(2E)-hex-2-enoylsulfanyl]ethyl}carbamoyl)ethyl]carbamoyl}-3-hydroxy-2,2-dimethylpropoxy)(hydroxy)phosphoryl]oxy}(hydroxy)phosphoryl)oxy]methyl}-4-hydroxyoxolan-3-yl]oxy}phosphonic acid | 863.661 C27H44N7O17P3S | ||
ECMDB11121 | trans-2-Enoyl-OPC6-CoA | (2R)-4-({[({[(2R,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-3,3-dimethyl-N-{2-[(2-{[(2E)-6-[(1R,2S)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl]hex-2-enoyl]sulfanyl}ethyl)-C-hydroxycarbonimidoyl]ethyl}butanimidic acid | fatty acid oxidation PW000758 | 1013.879 C37H58N7O18P3S | |
ECMDB11120 | trans-2-Enoyl-OPC4-CoA | (2R)-4-({[({[(2R,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-2-hydroxy-3,3-dimethyl-N-{2-[(2-{[(2E)-4-[(1S,2S)-3-oxo-2-[(2Z)-pent-2-en-1-yl]cyclopentyl]but-2-enoyl]sulfanyl}ethyl)-C-hydroxycarbonimidoyl]ethyl}butanimidic acid | fatty acid oxidation PW000758 | 985.826 C35H54N7O18P3S | |
ECMDB20197 | Trans-2,3-Dihydroxycinnamate 31082-90-3 | (2E)-3-(2,3-dihydroxyphenyl)prop-2-enoic acid | Phenylalanine metabolism PW000921 | 180.1574 C9H8O4 | |
ECMDB23860 | trans-2,3-Dehydroacyl-CoA | 2-hydroxy-2-(4-hydroxyphenyl)acetonitrile | 149.1467 C8H7NO2 | ||
ECMDB11123 | trans,cis-Lauro-2,6-dienoyl-CoA | (2R)-4-({[({[(2R,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)-N-[2-({2-[(2E,5Z)-dodeca-2,5-dienoylsulfanyl]ethyl}-C-hydroxycarbonimidoyl)ethyl]-2-hydroxy-3,3-dimethylbutanimidic acid | Fatty acid metabolism PW000796 | 945.805 C33H54N7O17P3S | |
ECMDB02054 | Tiglyl-CoA | {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-2-({[hydroxy({hydroxy[3-hydroxy-2,2-dimethyl-3-({2-[(2-{[(2E)-2-methylbut-2-enoyl]sulfanyl}ethyl)carbamoyl]ethyl}carbamoyl)propoxy]phosphoryl}oxy)phosphoryl]oxy}methyl)oxolan-3-yl]oxy}phosphonic acid | 849.635 C26H42N7O17P3S |